T7‐MNTs showed the targeting ability to the lysosomes in the breast cancer cells, which offer a physical and biological platform to collaboratively achieve GPX4 inhibition and ferroptosis induction in vivo. This evidence concerns the gene GPX4 and breast carcinoma.